| Daniel C Voglewede, MD | |
|
7420 Remcon Cir, Bldg A, El Paso, TX 79912-3508 | |
| (915) 532-8823 | |
| (915) 532-5909 |
| Full Name | Daniel C Voglewede |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 49 Years |
| Location | 7420 Remcon Cir, El Paso, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588636633 | NPI | - | NPPES |
| 135772504 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | G2504 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Medical Center | Las cruces, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rio Grande Urology Pa | 3476627878 | 31 |
News Archive
Kansas will send back its $31.5 million Early Innovator Grant to the Department of Health and Human Services, which would have helped pay for the development of the state's online insurance exchange. Gov. Sam Brownback said he was returning the money because of doubts that the federal government would be able to maintain its promised future payments.
NorthShore University HealthSystem's Center for Personalized Medicine and Ambry Genetics Corporation, announced today the launch of AmbryScore for prostate cancer risk.
Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).
The first treatments with Elekta Volumetric Modulated Arc Therapy (VMAT) began November 17, 2009 at Roseville Radiation Oncology Center (ROC) at Radiological Associates of Sacramento (RAS). RAS, a large private medical group, includes diagnostics as well as therapy in its centers. ROC treats 30-35 patients per day, mainly with prostate and breast lesions.
› Verified 2 days ago
| Entity Name | Rio Grande Urology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750416921 PECOS PAC ID: 3476627878 Enrollment ID: O20080804000040 |
News Archive
Kansas will send back its $31.5 million Early Innovator Grant to the Department of Health and Human Services, which would have helped pay for the development of the state's online insurance exchange. Gov. Sam Brownback said he was returning the money because of doubts that the federal government would be able to maintain its promised future payments.
NorthShore University HealthSystem's Center for Personalized Medicine and Ambry Genetics Corporation, announced today the launch of AmbryScore for prostate cancer risk.
Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).
The first treatments with Elekta Volumetric Modulated Arc Therapy (VMAT) began November 17, 2009 at Roseville Radiation Oncology Center (ROC) at Radiological Associates of Sacramento (RAS). RAS, a large private medical group, includes diagnostics as well as therapy in its centers. ROC treats 30-35 patients per day, mainly with prostate and breast lesions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel C Voglewede, MD 7420 Remcon Cir, Bldg A, El Paso, TX 79912-3508 Ph: (915) 532-8823 | Daniel C Voglewede, MD 7420 Remcon Cir, Bldg A, El Paso, TX 79912-3508 Ph: (915) 532-8823 |
News Archive
Kansas will send back its $31.5 million Early Innovator Grant to the Department of Health and Human Services, which would have helped pay for the development of the state's online insurance exchange. Gov. Sam Brownback said he was returning the money because of doubts that the federal government would be able to maintain its promised future payments.
NorthShore University HealthSystem's Center for Personalized Medicine and Ambry Genetics Corporation, announced today the launch of AmbryScore for prostate cancer risk.
Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).
The first treatments with Elekta Volumetric Modulated Arc Therapy (VMAT) began November 17, 2009 at Roseville Radiation Oncology Center (ROC) at Radiological Associates of Sacramento (RAS). RAS, a large private medical group, includes diagnostics as well as therapy in its centers. ROC treats 30-35 patients per day, mainly with prostate and breast lesions.
› Verified 2 days ago
Jesus Herrera-murillo, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 7420 Remcon Cir, El Paso, TX 79912 Phone: 915-532-8823 Fax: 915-225-2206 | |
Irene Mary Mcaleer, M.D. Urology Medicare: Medicare Enrolled Practice Location: 125 W Hague Rd Ste 360, El Paso, TX 79902 Phone: 915-533-2600 Fax: 915-533-2605 | |
Lauren Nicole Eisenberg, D,O. Urology Medicare: Accepting Medicare Assignments Practice Location: 7420 Remcon Circle, Bldg. A, El Paso, TX 79912 Phone: 915-532-8823 Fax: 915-532-5909 | |
Mauricio Davalos, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10175 Gateway Blvd W, Suite 320, El Paso, TX 79925 Phone: 915-225-2456 Fax: 915-503-2112 | |
Dr. Richard William Farnam, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4501 N Mesa St, El Paso, TX 79912 Phone: 915-533-5600 Fax: 915-533-5604 | |
Mr. Timo Frank Briffa, ACNPC-AG Urology Medicare: Accepting Medicare Assignments Practice Location: 7420 Remcon Cir Ste A, El Paso, TX 79912 Phone: 915-532-8823 | |
Dr. Michael Joseph Sebesta, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 Trans Mountain Rd, El Paso, TX 79911 Phone: 915-271-4586 Fax: 915-271-4587 |